Table 1.
Gene targets identified in regulator mutants.
Mutanta | Defectiveb | Amplifiedb |
---|---|---|
Source regulators | ||
hog1Δ (3) | 1378 | 565 |
pde2Δ (3) | 517 | 59 |
mck1Δ (3) | 794 | 101 |
msn2Δ (3) | 184 | 26 |
rim101Δ (3) | 75 | 227 |
gpb2Δ (2) | 202 | 37 |
rim15Δ (2) | 438 | 106 |
npr2Δ (2) | 75 | 69 |
npr3Δ (2) | 184 | 89 |
swc3Δ (2) | 108 | 257 |
swc5Δ (2) | 84 | 55 |
whi2Δ (2) | 118 | 201 |
pph3Δ (2) | 235 | 21 |
sub1Δ (2) | 431 | 97 |
tpk1Δ (2) | 35 | 96 |
ygr122wΔ (2) | 106 | 502 |
Validation mutants | ||
cdc14-3 (3)c | 929 | 346 |
nnk1Δ (1) | 94 | 278 |
bck1Δ (1) | 107 | 169 |
yak1Δ (1) | 226 | 248 |
kin2Δ (1) | 52 | 266 |
pho85Δ (1) | 614 | 342 |
cka2Δ (2) | 155 | 63 |
cka1Δ (2) | 58 | 133 |
ckb1Δ ckb12Δ (2) | 129 | 176 |
arf3Δ (2) | 466 | 331 |
scd6Δ (2) | 0 | 0 |
Mutant and number of replicates in parentheses.
Number of genes with smaller (defective) or larger (amplified) expression changes compared to the wild-type strain. Note, this table includes non-coding RNAs that were excluded from the inference. The table lists the number of targets identified from the originally interrogated ‘source’ regulators and validation mutants.
cdc14-3 was compared to its isogenic and identically treated wild-type.